Copyright: ©Author(s) 2026.
World J Psychiatry. Nov 19, 2026; 16(11): 123323
Published online Nov 19, 2026. doi: 10.5498/wjp.123323
Published online Nov 19, 2026. doi: 10.5498/wjp.123323
Table 3 Comparison of anxiety and depression between two groups (points), mean ± SD
| Parameter | Conventional group (n = 104) | Multicomponent group (n = 96) | t value | P value |
| GAI-SF scores | ||||
| Baseline | 3.82 ± 0.37 | 3.91 ± 0.42 | 1.604 | 0.110 |
| 3 months | 3.18 ± 0.41 | 2.94 ± 0.66 | 3.048 | 0.003 |
| GDS-15 scores | ||||
| Baseline | 9.47 ± 1.65 | 9.82 ± 1.83 | 1.433 | 0.154 |
| 3 months | 8.89 ± 1.82 | 8.04 ± 2.18 | 3.018 | 0.003 |
- Citation: Chen YF, Zhu Y, Li BX, Zhang JN. Impact of multicomponent, nonpharmacological care program for mild Alzheimer’s disease with anxiety and depression. World J Psychiatry 2026; 16(11): 123323
- URL: https://www.wjgnet.com/2220-3206/full/v16/i11/123323.htm
- DOI: https://dx.doi.org/10.5498/wjp.123323